Tarantino, G.; Imbimbo, C.; Ferro, M.; Bianchi, R.; La Rocca, R.; Lucarelli, G.; Lasorsa, F.; Busetto, G.M.; Finati, M.; Pastore, A.L.;
et al. Which Surrogate Marker of Insulin Resistance Among Those Proposed in the Literature Better Predicts the Presence of Non-Metastatic Bladder Cancer? J. Clin. Med. 2025, 14, 2636.
https://doi.org/10.3390/jcm14082636
AMA Style
Tarantino G, Imbimbo C, Ferro M, Bianchi R, La Rocca R, Lucarelli G, Lasorsa F, Busetto GM, Finati M, Pastore AL,
et al. Which Surrogate Marker of Insulin Resistance Among Those Proposed in the Literature Better Predicts the Presence of Non-Metastatic Bladder Cancer? Journal of Clinical Medicine. 2025; 14(8):2636.
https://doi.org/10.3390/jcm14082636
Chicago/Turabian Style
Tarantino, Giovanni, Ciro Imbimbo, Matteo Ferro, Roberto Bianchi, Roberto La Rocca, Giuseppe Lucarelli, Francesco Lasorsa, Gian Maria Busetto, Marco Finati, Antonio Luigi Pastore,
and et al. 2025. "Which Surrogate Marker of Insulin Resistance Among Those Proposed in the Literature Better Predicts the Presence of Non-Metastatic Bladder Cancer?" Journal of Clinical Medicine 14, no. 8: 2636.
https://doi.org/10.3390/jcm14082636
APA Style
Tarantino, G., Imbimbo, C., Ferro, M., Bianchi, R., La Rocca, R., Lucarelli, G., Lasorsa, F., Busetto, G. M., Finati, M., Pastore, A. L., Al Salhi, Y., Fuschi, A., Terracciano, D., Giampaglia, G., Falabella, R., Barone, B., Fusco, F., Del Giudice, F., & Crocetto, F.
(2025). Which Surrogate Marker of Insulin Resistance Among Those Proposed in the Literature Better Predicts the Presence of Non-Metastatic Bladder Cancer? Journal of Clinical Medicine, 14(8), 2636.
https://doi.org/10.3390/jcm14082636